Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $746.37 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $366.72 | 4 | $0 (2018) |
| Genentech USA, Inc. | $100.69 | 1 | $0 (2022) |
| Alcon Vision LLC | $96.91 | 5 | $0 (2022) |
| TissueTech, Inc. | $58.03 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $21.12 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $20.20 | 1 | $0 (2020) |
| Shire North American Group Inc | $19.73 | 1 | $0 (2017) |
| Alcon Laboratories Inc | $18.20 | 1 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $14.97 | 1 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $14.95 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14.97 | 1 | Apellis Pharmaceuticals, Inc. ($14.97) |
| 2022 | $137.13 | 3 | Genentech USA, Inc. ($100.69) |
| 2021 | $35.34 | 2 | Alcon Vision LLC ($35.34) |
| 2020 | $60.18 | 3 | Alcon Vision LLC ($25.13) |
| 2019 | $58.03 | 1 | TissueTech, Inc. ($58.03) |
| 2018 | $170.76 | 4 | AbbVie, Inc. ($116.49) |
| 2017 | $269.96 | 4 | AbbVie, Inc. ($250.23) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/12/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: Ophthalmology | ||||||
| 08/08/2022 | Alcon Vision LLC | ARGOS (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Ophthalmology | ||||||
| 07/06/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Glaucoma | ||||||
| 05/16/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $100.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/11/2021 | Alcon Vision LLC | AcrySof IQ PanOptix (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Ophthalmology | ||||||
| 03/17/2021 | Alcon Vision LLC | AcrySof IQ VIVITY IOL (Device) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Ophthalmology | ||||||
| 11/10/2020 | Alcon Vision LLC | AcrySof IQ PanOptix (Device) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Ophthalmology | ||||||
| 02/20/2020 | Aerie Pharmaceuticals, Inc. | rhopressa (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Glaucoma | ||||||
| 02/12/2020 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Ophthalmology | ||||||
| 04/08/2019 | TissueTech, Inc. | Prokera (Device), AmnioGraft, AmnioGuard | Food and Beverage | Cash or cash equivalent | $58.03 | General |
| Category: Medical Device (510K) | ||||||
| 10/09/2018 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Multifocal Family of 1-piece IOLS (Device), Unfolder IOL Delivery Systems | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Optics | ||||||
| 08/29/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $116.49 | General |
| Category: Immunology | ||||||
| 03/29/2018 | Alcon Laboratories Inc | ReSTOR (Device) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Ophthalmology | ||||||
| 03/20/2018 | Novartis Pharmaceuticals Corporation | PAZEO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $118.00 | General |
| Category: Immunology | ||||||
| 05/04/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $119.13 | General |
| Category: Immunology | ||||||
| 02/16/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: OPTHALMICS | ||||||
| 01/19/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,984 | 5,049 | $2.0M | $758,696 |
| 2022 | 18 | 2,856 | 4,842 | $1.9M | $768,881 |
| 2021 | 19 | 2,867 | 4,913 | $2.1M | $895,695 |
| 2020 | 17 | 2,808 | 5,119 | $2.1M | $893,646 |
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 53 | 632 | $790,000 | $427,125 | 54.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 834 | 934 | $234,345 | $77,521 | 33.1% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 107 | 172 | $307,020 | $71,433 | 23.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 117 | 532 | $178,500 | $53,444 | 29.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 77 | 392 | $58,800 | $26,535 | 45.1% |
| 92134 | Imaging of retina | Office | 2023 | 291 | 724 | $76,020 | $21,673 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 189 | 189 | $70,875 | $18,397 | 26.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 42 | 44 | $47,125 | $13,308 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 159 | 247 | $27,415 | $9,397 | 34.3% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 157 | 180 | $38,700 | $7,753 | 20.0% |
| 92133 | Imaging of optic nerve | Office | 2023 | 278 | 302 | $31,710 | $7,086 | 22.3% |
| 92250 | Photography of the retina | Office | 2023 | 277 | 285 | $51,300 | $6,943 | 13.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 104 | 112 | $14,000 | $6,806 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 71 | $11,715 | $4,628 | 39.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 106 | 108 | $22,010 | $3,730 | 16.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Facility | 2023 | 78 | 78 | $5,850 | $1,836 | 31.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $3,740 | $904.86 | 24.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 25 | 25 | $875.00 | $177.10 | 20.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 59 | 626 | $782,500 | $447,596 | 57.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 815 | 929 | $222,960 | $77,308 | 34.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 110 | 169 | $301,665 | $70,103 | 23.2% |
| 67028 | Injection of drug into eye | Office | 2022 | 107 | 532 | $176,000 | $52,978 | 30.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 71 | 375 | $56,250 | $26,003 | 46.2% |
| 92134 | Imaging of retina | Office | 2022 | 279 | 711 | $74,535 | $21,525 | 28.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 169 | 169 | $63,375 | $14,810 | 23.4% |
About Dr. Scott Stevens, MD
Dr. Scott Stevens, MD is a Ophthalmology healthcare provider based in Klamath Falls, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306055413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Stevens, MD has received a total of $746.37 in payments from pharmaceutical and medical device companies, with $14.97 received in 2023. These payments were reported across 18 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($746.37).
As a Medicare-enrolled provider, Stevens has provided services to 11,515 Medicare beneficiaries, totaling 19,923 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Klamath Falls, OR
- Active Since 05/22/2007
- Last Updated 02/11/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1306055413
Products in Payments
- Humira (Biological) $366.72
- VABYSMO (Drug) $100.69
- Prokera (Device) $58.03
- AcrySof IQ PanOptix (Device) $49.36
- rhopressa (Drug) $36.85
- PAZEO (Drug) $21.12
- ARGOS (Device) $19.79
- XIIDRA (Drug) $19.73
- ReSTOR (Device) $18.20
- Syfovre (Drug) $14.97
- Tecnis Multifocal Family of 1-piece IOLS (Device) $14.95
- Omidria (Drug) $14.85
- AcrySof IQ VIVITY IOL (Device) $11.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Klamath Falls
Dr. Jonathan Fay, M.d, M.D
Ophthalmology — Payments: $1,471
Dr. Mark Fay, M.d, M.D
Ophthalmology — Payments: $1,359
Teresa Graham, Md, MD
Ophthalmology — Payments: $637.41
Dr. Daniel Benson, M.d, M.D
Ophthalmology — Payments: $54.01